InvestorsHub Logo
Followers 3
Posts 119
Boards Moderated 0
Alias Born 03/02/2013

Re: None

Friday, 03/05/2021 6:49:26 PM

Friday, March 05, 2021 6:49:26 PM

Post# of 232197
Can someone refresh my memory on what the mortality benefit was on Remdesavir? Last time I checked, this received approval. The writing is on the wall, read the last paragraph. A recently approved Il-6 blocker reduced mortality by 2% versus standard of care. How could this even be perceived as a failure versus what has been recently approved?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News